📣 New publication alert! Congratulations to CCANDL’s Deling He on her recent publication! This study found that incorporating proper name recall into a commonly used cognitive assessment enhanced its sensitivity to plasma p-tau217, a key biomarker for Alzheimer’s disease. Congratulations Deling!
Congratulations to CCANDL’s biostatistician Kristin Basche and collaborators on their recent publication examining proper name recall and pTau217 as potential markers of early cognitive decline in Alzheimer’s disease research. This work highlights how subtle changes in memory can help identify cognitive decline earlier in at-risk adults.
Big news from the Gilmore-Bykovskyi Lab and CCANDL! 📢 📝 We’re excited to celebrate PhD student Haley Colgate Kottler on her new publication: “Data-driven detection of lucid episodes in advanced dementia.” This innovative project leveraged data from transcribed speech to identify moments of clarity using latent class analysis—an important step forward in understanding lucidity in dementia. …
Check out CCANDL post-doc, Deling He’s latest publication on the development of a novel language composites to better capture ecologically valid measurements that are also more sensitive to plasma biomarkers! #alzheimers #alzheimersresearch #dementia #Biomarkershttps://doi.org/10.1002/alz.70975
Our lab is excited to share our latest work, Proper Name Recall as an Early Indicator of Preclinical Alzheimer Disease Pathology.Congrats to lab members Kristin, Madeline, and Deling for their contributions to this work.Click the link to read more: https://doi.org/10.1097/wad.0000000000000695
Check out Kristin Basche’s, CCANDL biostatistician, recent publication! Click the link below to read more about her work, diving into how amyloid and tau affect memory in a cognitively unimpaired at-risk sample. #memory #alzheimersresarch #cognitiveaging https://academic.oup.com/…/article/7/5/fcaf390/8280085…